




1.1.  Background 
Inflammation can be defined as an immune response to harmful stimuli, for instance 
damaged cells, pathogens, irradiation and toxic compounds (Medzhitov, 2010), then it 
will remove harmful stimuli and start the recovery process (Ferrero-Miliani, Nielsen, 
Andersen, & Girardin, 2007). In other words, inflammation is humans’ body defense 
mechanism which is important to health (Nathan & Ding, 2010). Generally, cellular and 
molecular interactions will reduce the infection or injury during acute inflammatory 
responses. This mitigation process will help restore the tissue homeostasis and resolve 
the acute inflammation. However, there is very possibile that uncontrolled acute 
inflammation may be the cause of chronic inflammatory diseases, e.g. cardiovascular 
diseases, neurological diseases, endothelial dysfunctions, and infection (Carrero, Yilmaz, 
Lindholm, & Stenvinkel, 2008; Machowska, Carrero, Lindholm, & Stenvinkel, 2016; 
Zhou, Hong, & Huang, 2016). 
Bacterial lipopolysaccharides (LPS) is a powerful immunostimulant that may cause 
inflammation, fever and septic shock, which may lead to death of the patient. A strong 
inflammatory response will be trigerred when bacteria multipy in the bloodstream 
because the bloodstream is the ideal transportion method for bacteria to spread in the 
body. Immune cells in the blood are very sensitive to LPS and may cause excessive 
inflammation, which can lead to organ failure and patient death. This phenomenon is also 
called septic shock (Opal, 2010; Salomao et al., 2012). 
The mechanism of inflammation is as follows : stimuli will trigger the activation of 
inflammatory cells, for examples macrophages and adipocytes; afterwards, cytokines, 
proteins and enzymes related to inflamation are produced (Chen et al., 2018). Therefore, 
inflammation-related cytokines, proteins and enzymes are commonly used as biomarkers 
for diseases diagnosis, prognosis, and therapeutic decision making (Bhowmik, 
Seemungal, Sapsford, & Wedzicha, 2000; Lindahl, Toss, Siegbahn, Venge, & Wallentin, 
2000; Cesari et al., 2003; Pecoits-Filho et al., 2003; Shlipak et al., 2003; Pai et al., 2004; 
Bautista, Vera, Arenas, & Gamarra, 2005; Goldstein, Kemp, Soczynska, & McIntyre, 




Nowadays, people are paying more and more attention to edible dark-colored fruits, 
which are abundant with anthocyanins, because of their health benefit. One of the 
example is Jaboticaba  (Myrciaria cauliflora (Mart.) O. Berg) fruit, a native Brazilian 
fruit. Jaboticaba fruit contains many bioactive compounds exhibited several properties 
such as anti-inflammatory, antioxidant, anti-diabetes, and anti-cancer, as well as 
preventing from COPD (Chronic Obstructive Pulmonary Disease), cardiovascular 
diseases, and stroke (Wu, Long, & Kennelly, 2013). According to reports, the biologically 
active compounds in Jaboticaba are carotenoids, anthocyanins, tannins, phenolic acids 
and lesser-known polyphenols, such as depsides (Einbond, Reynertson, Luo, Basile, & 
Kennelly, 2004; Reynertson et al., 2006; Plagemanna, Kringsa, Bergera, & Marostica, 
2012; Wu, Dastmalchi, Long, & Kennelly, 2012). 
Zebrafish, also called Danio rerio, is a small vertebrate fish which habitates in 
tropical freshwater. It has gathered attention as beneficial vertebrate model organism due 
to the tiny size, sizeable clutches of eggs, transparency, low-up keep, and morphological 
& physiological similarity to mammals (Eisen, 1996; Fishman, 1999). Lately, the merit 
of the zebrafish as modal animal for in vivo drug toxicity and efficacy studies has been 
acknowledged due to the advantages mentioned above (Ali, Champagne, Spaink, & 
Richardson, 2011; Den Hertog, 2005; He et al., 2013).On the other side, the optical 
translucency of zebrafish embryos helps in noninvasive and dynamic imaging of 
inflammation in vivo. Thus, zebrafish model is widely adopted and it is considered as one 
of the best methods for anti-inflammation determination (Lee et al., 2013; Liao et al., 
2011; K. H. Park & Cho, 2011). 
The use of Jaboticaba to treat inflammatory diseases has been previously studied.  
Reynertson et al., (2006) investigated the effect of 2-O-(3,4-dihydroxybenzoyl)-
2,4,6trihydroxyphenylacetic acid and jaboticabin, potential bio-compounds  in jaboticaba 
fruit, on  COPD (Chronic Obstuctive Pulmonary Disease) characterized  by irreversible 
airflow  obstruction,  using SAE (Small Airway Epithelial) cells treated with cigarette 
smoke extract (CSE). It was reported that bio-compound of (2-O-(3,4-
dihydroxybenzoyl)-2,4,6trihydroxyphenylacetic acid) reduced IL-8 production up to 
81.3% in SAE cells without CSE treatment. While SAE cells treated with CSE had 
decreased 47.3% of IL-8 level.  Jaboticabin may also attenuate IL-8 production up to 




Zhao et al. (2019) updated research to explore more information about different parts 
of Jaboticabin (including peel, seeds, pulp and veneer) and applied it to SAE cells treated 
with CSE to confirm the role of Jabaticabin on COPD.  From the report,  Jaboticabin 
significantly decrease IL-8 levels up to 523.28 pg/mL in CSE-induced and 190.50 pg/mL 
in non-induced SAE cells. In vivo studies conducted by da Silva-Maia et al. (2019) and  
Lamas et al. (2020) also observed the anti-inflammatory effect of jaboticaba using murine 
model. Even many reports have shown positive effects of jaboticaba on many health-
related disorders, scientific study regarding the effect of jaboticaba on neuroinflammation 
is limited. Therefore, the purpose of this study is to explore the anti-inflammatory 
mechanism of jaboticaba fruit in LPS-induced zebrafish.  
